Pharmacological Screening of Kv7.1 and Kv7.1/KCNE1 Activators as Potential Antiarrhythmic Drugs in the Zebrafish Heart
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms241512092 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Alicia De la Cruz und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Biophysics, Miller School of Medicine, University of Miami, 1600 NW 10th Avenue, Miami, FL 33136, USA. Hauptthemen laut MEDLINE: Long QT Syndrome, Potassium Channels, Voltage-Gated. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Long QT syndrome (LQTS) can lead to ventricular arrhythmia and sudden cardiac death. The most common congenital cause of LQTS is mutations in the channel subunits generating the cardiac potassium current IKs. Zebrafish (Danio rerio) have been proposed as a powerful system to model human cardiac diseases due to the similar electrical properties of the zebrafish heart and the human heart. We used high-resolution all-optical electrophysiology on ex vivo zebrafish hearts to assess the effects of IKs analogues on the cardiac action potential. We found that chromanol 293B (an IKs inhibitor) prolonged the action potential duration (APD) in the presence of E4031 (an IKr inhibitor applied to drug-induced LQT2), and to a lesser extent, in the absence of E4031. Moreover, we showed that PUFA analogues slightly shortened the APD of the zebrafish heart. However, PUFA analogues failed to reverse the APD prolongation in drug-induced LQT2. However, a more potent IKs activator, ML-277, partially reversed the APD prolongation in drug-induced LQT2 zebrafish hearts. Our results suggest that IKs plays a limited role in ventricular repolarizations in the zebrafish heart under resting conditions, although it plays a more important role when the IKr is compromised, as if the IKs in zebrafish serves as a repolarization reserve as in human hearts. This study shows that potent IKs activators can restore the action potential duration in drug-induced LQT2 in the zebrafish heart.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology and Biophysics, Miller School of Medicine, University of Miami, 1600 NW 10th Avenue, Miami, FL 33136, USA.
- Department of Biomedical and Clinical Sciences, Linköping University, SE-581 85 Linköping, Sweden.
ORCID-Profile: Alicia De la Cruz, Xiaoan Wu, Quinn C Rainer, Isak Edler, H Peter Larsson
Förderung
- NHLBI NIH HHS
- NIH HHS
- National Institutes of Health
- European Union
Zitieren
APA
De la Cruz, A., Wu, X., Rainer, Q. C., Hiniesto-Iñigo, I., Perez, M. E., Edler, I., Liin, S. I., & Larsson, H. P. (2023). Pharmacological Screening of Kv7.1 and Kv7.1/KCNE1 Activators as Potential Antiarrhythmic Drugs in the Zebrafish Heart. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241512092
Vancouver
De la Cruz A, Wu X, Rainer QC, Hiniesto-Iñigo I, Perez ME, Edler I, et al. Pharmacological Screening of Kv7.1 and Kv7.1/KCNE1 Activators as Potential Antiarrhythmic Drugs in the Zebrafish Heart. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241512092
BibTeX
@article{DelaCruz2023,
author = {De la Cruz, Alicia and Wu, Xiaoan and Rainer, Quinn C and Hiniesto-Iñigo, Irene and Perez, Marta E and Edler, Isak and Liin, Sara I and Larsson, H Peter},
title = {Pharmacological Screening of Kv7.1 and Kv7.1/KCNE1 Activators as Potential Antiarrhythmic Drugs in the Zebrafish Heart},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms241512092}
}
EUVIMED